Application from citizens of Meghalaya are urgently required for appointment on a contractual basis for a period of 2 years (renewable) for the following post under Meghalayan Medical Drugs & Services Ltd, Meghalaya

Post: Pharmacist

National Institute of Pharmaceutical Education and Research (NIPERs) have been created by an act of Parliament and each institute is an autonomous body functioning under the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, Govt. of India. Having been declared as “Institutes of National Importance”. NIPERs have been contributing to the growth of the Pharmaceutical Education and Research to meet the country's progress towards skilled professionals in the pharmaceutical industry.

All India Institute of Medical Sciences, New Delhi (AIIMS Delhi) is one of India’s premier medical institutions for healthcare, medical education, and biomedical research. Established in 1956, it operates under the Ministry of Health and Family Welfare, Government of India. AIIMS Delhi provides specialized and advanced medical care across a wide range of clinical departments. The institute is also a major centre for medical research, clinical studies, and development of healthcare technologies.

The Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, is a research institution under the Biotechnology Research and Innovation Council (BRIC), Department of Biotechnology, Ministry of Science and Technology, Government of India. BRIC–CDFD is a premier institute in the country, which provides services in the areas of DNA Fingerprinting and Diagnostics and performs cutting-edge research in several frontier areas of modern biology.

PhD-I-2027 Admissions

This institute intends to engage Senior Research Fellows (Life Sciences) on a contractual basis for the ongoing Research project "Impact of Muktashukti Bhasma and Saubhagya Shunthi in reversal of bone mineral density among lactating women consuming traditional diet food in Maharashtra-A randomized controlled preliminary clinical study" for the year 2026-27.

Post: Senior Research Fellow (Life Sciences) - 01

The National Forensic Sciences University (NFSU), headquartered in Gandhinagar, Gujarat, is an Institution of National Importance established by the Government of India under the National Forensic Sciences University Act, 2020. It is dedicated to education, research, training and innovation in forensic science, cybersecurity, digital forensics, behavioural sciences, criminology, law, pharmacy and other allied disciplines.

The Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) is a multidisciplinary research institute located in Jakkur, Bengaluru, established in 1989 by the Department of Science and Technology, Government of India. The Centre focuses on advanced research and training in frontier areas of science and engineering, including materials science, chemistry, physics, biology, genetics, engineering and neuroscience.

National Chemical Laboratory (NCL), Pune, is a premier research laboratory under the Council of Scientific & Industrial Research (CSIR), Government of India. Established in 1950, NCL conducts advanced research in chemistry, chemical engineering, biotechnology, and related scientific disciplines. The institute works on areas such as drug discovery, catalysis, polymers, materials science, and sustainable chemical processes. NCL also collaborates with academic institutions and industries to translate scientific research into practical applications.

Established in 1984, the CSIR-Institute of Microbial Technology (IMTech) is one among the chain of 38 national laboratories, 6 units and 39 outreach centres of the Council of Scientific & Industrial Research. Set-up to be a fore-runner in the niche domain of microbial biotechnology, the Institute in its initial years functioned from a start-up laboratory that provided a truly world-class R&D ambience in an area of over 10,000 sq. ft. to its researchers.

National Institute of Science Education and Research (NISER), Bhubaneswar is an autonomous research institute under the Department of Atomic Energy, Government of India, affiliated with Homi Bhabha National Institute (HBNI). Established in 2007, NISER focuses on advanced education and research in fundamental sciences, including biology, chemistry, mathematics and physics, along with interdisciplinary areas. The institute offers integrated and doctoral programmes and conducts frontier research through its specialized schools and research facilities.

For the past 25 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle.

Are you ready to play a central role in how Novo Nordisk governs pharmacovigilance excellence across the globe? This is your chance to help shape the systems, processes and training frameworks that keep our pharmacovigilance operations compliant, inspection-ready and continuously improving – directly supporting patient safety at scale.

Post: PV Process Excellence Specialist

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing.

Strides Pharma Science Limited is a Bengaluru-headquartered global pharmaceutical company established in 1990. The company develops and manufactures IP-led niche and complex generic medicines and serves regulated and emerging markets across 100+ countries. Strides has capabilities across multiple dosage forms, including tablets, capsules, sachets, liquids, nasal sprays, topical products and other specialized formulations. Its R&D activities focus on complex generics, novel drug-delivery systems and differentiated formulations.

Walk-in Recruitment Drive @ Bengaluru

Swiss Parenterals Limited is an Ahmedabad-based pharmaceutical company specializing in the development and manufacturing of generic and specialty pharmaceutical products, particularly sterile injectables. The company has more than 25 years of experience and operates as a dossier-driven pharmaceutical business serving international markets.  Swiss focuses on sterile injectable products, including liquid vials, lyophilized products and other complex dosage forms.

H&H Healthcare and Cosmetics Pvt. Ltd. is a B2B healthcare and contract development and manufacturing organization (CDMO) based in Madhya Pradesh, with its manufacturing facility located at Smart Industrial Park, Pithampur. The company develops and manufactures nutraceutical, herbal, Ayurvedic and healthcare products, with capabilities covering R&D, formulation development, manufacturing, packaging and private-label solutions.

Kusum Group of Companies is a global pharmaceutical group headquartered in New Delhi, India, with manufacturing and R&D operations across multiple countries. Through Kusum Healthcare, the group manufactures a range of pharmaceutical formulations including tablets, pellets, topical products and other dosage forms at its facilities in India. The group focuses on providing high-quality, affordable medicines for international markets and operates manufacturing facilities that follow international GMP and quality standards.

The United States has included India, China and Pakistan among 23 countries designated as major drug transit or major illicit drug-producing countries for fiscal year 2027. The designation was submitted to the U.S. Congress on September 15, 2026, as part of the annual U.S. “Major’s List,” which identifies countries considered significant sources or transit points for illicit drugs entering the United States.

Dr. Reddy’s Laboratories has expanded its collaboration with Gilead Sciences through a royalty-free, non-exclusive voluntary licensing agreement covering investigational once-yearly lenacapavir for HIV prevention. The agreement builds on the companies’ existing 2024 licensing arrangement for lenacapavir and is intended to support future manufacturing readiness, technology transfer and supply planning in licensed territories.